FDA Import Refusal 1FX-5695096-7/20002/1 — Boehringer Ingelheim Canada
The FDA refused shipment 1FX-5695096-7/20002/1 from Boehringer Ingelheim Canada (Canada) on Jul 24, 2026. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jul 24, 2026
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75